Physician profile
William Benjamin Rothstein
NPI 1639557358
$3,258.01
in general payments reported to CMS, 2019-2025
8 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $447 · 2023: $586 · 2024: $880 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632 · Travel and Lodging: $635 · Education: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.79 |
| Travel and Lodging | $634.95 |
| Education | $543.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,146.32 | 2022-2025 | Endurant Iis, Harmony, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $909.32 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Propaten Vascular Graft |
| Boston Scientific Corporation | $634.95 | 2025 | Enroute Transcarotid Neuroprotection System |
| Silk Road Medical, INC. | $186.09 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $168.40 | 2023-2024 | Alto Abdominal Stent Graft System |
| Shockwave Medical, INC | $151.85 | 2025 | |
| Innovation Technologies INC | $35.27 | 2023 | Irrisept |
| Smith+Nephew, INC. | $25.81 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.